July 10, 2014
Allos Therapeutics Inc. has recently hit Dr. Reddy's Laboratories Ltd. with a lawsuit in New Jersey federal court to halt the production of a generic form of cancer treatment drug Folotyn, saying it would infringe upon three Allos patents.